Florida Health Daily: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Florida Health Daily.

Press releases published on May 13, 2026

May 13, 2026

Kamada Reports First Quarter 2026 Financial Results and Affirms 2026 Annual Guidance; Expecting Significantly Stronger Remainder of the Year

Indeterminate GlobeNewswire

May 13, 2026

Zenas BioPharma Announces First Subject Dosed in Phase 1 Clinical Trial of ZB021, a Novel, Potentially Best-in-Class Oral IL-17AA/AF Inhibitor

Indeterminate GlobeNewswire

May 13, 2026

Veru Reports Fiscal 2026 Second Quarter Financial Results and Phase 2b PLATEAU Clinical Trial Progress

Indeterminate GlobeNewswire

May 13, 2026

Aprea Therapeutics Reports First Quarter 2026 Financial Results and Provides a Corporate Update

Indeterminate GlobeNewswire

May 13, 2026

Voyager ASGCT Late Breaker: Single IV Dose of VY1706 Well Tolerated, Reduced Tau in 3-Month GLP Toxicology Data; Clinical Trial in Alzheimer’s Disease Expected H2 2026

Indeterminate GlobeNewswire

May 13, 2026

Zymeworks Announces Participation in Upcoming Investor Conferences

Indeterminate GlobeNewswire

May 13, 2026

Zenas BioPharma Reports First Quarter 2026 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire

May 13, 2026

NVision Expands from Quantum Sensing to Quantum Computing to Accelerate Discovery and Validation of New Therapies

Indeterminate GlobeNewswire

May 13, 2026

HepaRegeniX to Present Interim Phase 1b Data for Darizmetinib (HRX215) in a Late-Breaking Oral Presentation at the European Association for the Study of the Liver (EASL) Congress 2026

Indeterminate GlobeNewswire

May 13, 2026

New Anglia University Highlights Growing Demand for International Medical Education Among British Students

Indeterminate GlobeNewswire

May 13, 2026

Anaveon Appoints Thomas P. Mathers as Chair of the Board of Directors

Indeterminate GlobeNewswire

May 13, 2026

Inventiva to Present Abstracts at the EASL Congress 2026

Indeterminate GlobeNewswire

May 13, 2026

Inventiva présentera plusieurs abstracts lors de l’EASL Congress 2026

Indeterminate GlobeNewswire

May 13, 2026

Fortis Life Sciences vergibt den AbNano® VHH Discovery Grant 2026 an Deliver Biosciences im Bereich der gezielten Wirkstoffabgabe

Indeterminate GlobeNewswire

May 13, 2026

Fortis Life Sciences attribue la subvention à la découverte AbNano® VHH Discovery 2026 à Deliver Biosciences pour la recherche sur l’administration ciblée de médicaments

Indeterminate GlobeNewswire

May 13, 2026

Aligos Therapeutics Announces Ten Abstracts Accepted for Presentation at the EASL Congress 2026

Indeterminate GlobeNewswire

May 13, 2026

Fangzhou Showcases “AI+H2H” Chronic Disease Service Innovations at the National Intelligent Medicine Conference

Indeterminate GlobeNewswire

May 13, 2026

Assembly Biosciences to Present Topline Phase 1a Data on Hepatitis Delta Virus Entry Inhibitor ABI-6250 at the EASL Congress 2026

Indeterminate GlobeNewswire

May 13, 2026

Valneva Reports First Quarter 2026 Financial Results and Provides Corporate Updates

Indeterminate GlobeNewswire

May 13, 2026

Valneva publie ses résultats financiers audités et consolidés pour le premier trimestre 2026

Indeterminate GlobeNewswire